UBS Group’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.7K | Sell |
3,620
-27,058
| -88% | -$192K | ﹤0.01% | 6972 |
|
|
2025
Q1 | $290K | Buy |
30,678
+18,138
| +145% | +$171K | ﹤0.01% | 5056 |
|
|
2024
Q4 | $112K | Buy |
12,540
+12,454
| +14,481% | +$112K | ﹤0.01% | 5580 |
|
|
2024
Q3 | $5.52K | Sell |
86
-407
| -83% | -$26.1K | ﹤0.01% | 6838 |
|
|
2024
Q2 | $37K | Buy |
493
+295
| +149% | +$22.1K | ﹤0.01% | 5771 |
|
|
2024
Q1 | $23.7K | Buy |
198
+158
| +395% | +$18.9K | ﹤0.01% | 5681 |
|
|
2023
Q4 | $3.32K | Sell |
40
-2
| -5% | -$166 | ﹤0.01% | 6778 |
|
|
2023
Q3 | $3.32K | Buy |
42
+2
| +5% | +$158 | ﹤0.01% | 6433 |
|
|
2023
Q2 | $2.34K | Sell |
40
-30
| -43% | -$1.76K | ﹤0.01% | 6682 |
|
|
2023
Q1 | $3.02K | Buy |
70
+15
| +27% | +$647 | ﹤0.01% | 7300 |
|
|
2022
Q4 | $2.82K | Hold |
55
| – | – | ﹤0.01% | 8422 |
|
|
2022
Q3 | $6K | Sell |
55
-77
| -58% | -$8.4K | ﹤0.01% | 7905 |
|
|
2022
Q2 | $16K | Buy |
132
+77
| +140% | +$9.33K | ﹤0.01% | 6145 |
|
|
2022
Q1 | $11K | Sell |
55
-118
| -68% | -$23.6K | ﹤0.01% | 7235 |
|
|
2021
Q4 | $34K | Buy |
173
+135
| +355% | +$26.5K | ﹤0.01% | 6150 |
|
|
2021
Q3 | $11K | Hold |
38
| – | – | ﹤0.01% | 6723 |
|
|
2021
Q2 | $14K | Buy |
38
+31
| +443% | +$11.4K | ﹤0.01% | 6598 |
|
|
2021
Q1 | $3K | Buy |
7
+2
| +40% | +$857 | ﹤0.01% | 7463 |
|
|
2020
Q4 | $3K | Buy |
+5
| New | +$3K | ﹤0.01% | 6956 |
|
|
2020
Q3 | – | Sell |
-4
| Closed | -$1K | – | 7108 |
|
|
2020
Q2 | $1K | Buy |
4
+2
| +100% | +$500 | ﹤0.01% | 6885 |
|
|
2020
Q1 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 6818 |
|
|
2019
Q1 | – | Sell |
-19
| Closed | -$9K | – | 6881 |
|
|
2018
Q4 | $9K | Buy |
19
+11
| +138% | +$5.21K | ﹤0.01% | 6346 |
|
|
2018
Q3 | $8K | Buy |
+8
| New | +$8K | ﹤0.01% | 6343 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7026 |
|
|
2018
Q1 | – | Sell |
-3
| Closed | -$13K | – | 6900 |
|
|
2017
Q4 | $13K | Buy |
+3
| New | +$13K | ﹤0.01% | 5885 |
|
|
2017
Q3 | – | Sell |
-1
| Closed | -$4K | – | 6774 |
|
|
2017
Q2 | $4K | Buy |
+1
| New | +$4K | ﹤0.01% | 6247 |
|
|
2016
Q3 | – | Sell |
-3
| Closed | -$35K | – | 6703 |
|
|
2016
Q2 | $35K | Buy |
3
+2
| +200% | +$23.3K | ﹤0.01% | 4938 |
|
|
2016
Q1 | $7K | Buy |
+1
| New | +$7K | ﹤0.01% | 5987 |
|
|
2015
Q4 | – | Hold |
0
| – | -$9K | – | 6872 |
|
|
2015
Q3 | – | Hold |
0
| – | -$4K | – | 5972 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6357 |
|